TIOTROPIUM Side Effects

6601999-5 | Accidental Overdose, Dry Mouth, Tachycardia, Urinary Retention
on Feb 19, 2010 Male patient from , 74 years of age, weighting 176.4 lb, was diagnosed with chronic obstructive pulmonary disease, hypothyroidism and was treated with Tiotropium (View Usage). Patient experienced the following unwanted or unexpected effects: accidental overdose, dry mouth, tachycardia, urinary retention. Tiotropium dosage: 90 Mcg. During the same period patient was treated with FLUTICASONE W/SALMETEROL (View Fluticasone W/salmeterol Review and Fluticasone W/salmeterol Label ), ALBUTEROL (View Albuterol Review and Albuterol Label ), LEVOTHYROXINE (View Levothyroxine Review and Levothyroxine Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), METOPROLOL SUCCINATE (12.5 Mg) (View Metoprolol Succinate Review and Metoprolol Succinate Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ). Patient was hospitalized.

6582727-9 | Urinary Retention
Patient was taking Tiotropium (View Usage). Patient had the following side effects: urinary retention on Feb 12, 2010 from UNITED STATES Additional patient health information: Female patient , 58 years of age, was diagnosed with chronic obstructive pulmonary disease and. Tiotropium dosage: 18 Mcg Every Day Po.

6582725-5 | Urinary Retention
Adverse event was reported on Feb 12, 2010 by a Male patient taking Tiotropium (View Usage) (Dosage: 18 Mcg Every Day Inhale) was diagnosed with chronic obstructive pulmonary disease and. Location: UNITED STATES , 66 years of age, After Tiotropium was administered, patient had the following side effects: urinary retention.

6578599-9 | Cataract
on Feb 04, 2010 Male patient from , weighting 209.4 lb, was diagnosed with asthma (What is asthma?), thrombosis prophylaxis and was treated with Tiotropium (View Usage). Patient experienced the following unwanted or unexpected effects: cataract (What is cataract?). Tiotropium dosage: 18 Mcg. During the same period patient was treated with PREDNISONE (25 Mg) (View Prednisone Review and Prednisone Label ), SALMETEROL FLUTICASONE (50 Mcg Salmeterol, 500 Mcg Fluticasone) (View Salmeterol-fluticasone Review and Salmeterol-fluticasone Label ), ALBUTEROL (View Albuterol Review and Albuterol Label ), MOMETASONE FUROATE (200 Mcg) (View Mometasone Furoate Review and Mometasone Furoate Label ), MONTELUKAST (10 Mg) (View Montelukast Review and Montelukast Label ), WARFARIN SODIUM (View Warfarin Sodium Review and Warfarin Sodium Label ).


6539623-2 | Agitation, Cyanosis, Dry Mouth, Dyspnoea, Feeling Of Body Temperature Change, Hallucination, Auditory, Hallucination, Visual, Hyperhidrosis, Loss Of Consciousness
on Jan 13, 2010 Male patient from , 61 years of age, was diagnosed with chronic obstructive pulmonary disease, hypercholesterolaemia and was treated with Tiotropium (View Usage). Patient had the following side effects: agitation, cyanosis, dry mouth, dyspnoea, feeling of body temperature change, hallucination, auditory, hallucination, visual, hyperhidrosis, loss of consciousness. Tiotropium dosage: . During the same period patient was treated with PAROXETINE (View Paroxetine Review and Paroxetine Label ), SCOPOLAMINE (View Scopolamine Review and Scopolamine Label ), ATROPINE (View Atropine Review and Atropine Label ), MONTELUKAST SODIUM (View Montelukast Sodium Review and Montelukast Sodium Label ), FLUTICASONE + SALMETEROL (View Fluticasone + Salmeterol Review and Fluticasone + Salmeterol Label ), ATORVASTATIN (View Atorvastatin Review and Atorvastatin Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), ALBUTEROL (View Albuterol Review and Albuterol Label ). Patient was hospitalized.

6537726-X | Accidental Overdose, Dry Mouth, Tachycardia, Urinary Retention
Patient was taking Tiotropium (View Usage). After Tiotropium was administered, patient had the following side effects: accidental overdose, dry mouth, tachycardia, urinary retention on Jan 06, 2010 from Additional patient health information: Male patient , 74 years of age, weighting 176.4 lb, was diagnosed with chronic obstructive pulmonary disease, hypothyroidism and. Tiotropium dosage: 90 Mcg. During the same period patient was treated with FLUTICASONE W/SALMETEROL (View Fluticasone W/salmeterol Review and Fluticasone W/salmeterol Label ), ALBUTEROL (View Albuterol Review and Albuterol Label ), LEVOTHYROXINE SODIUM (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), METOPROLOL SUCCINATE (12.5 Mg) (View Metoprolol Succinate Review and Metoprolol Succinate Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ). Patient was hospitalized.

6427150-2 | Oropharyngeal Pain
Adverse event was reported on Nov 03, 2009 by a Male patient taking Tiotropium (View Usage) (Dosage: 18 Mcg Every Day Inhale) . Location: UNITED STATES , 63 years of age, weighting 165.3 lb, Patient experienced the following unwanted or unexpected effects: oropharyngeal pain.

6168670-8 | Abdominal Pain, Urinary Retention
on Apr 24, 2009 Male patient from UNITED STATES , 54 years of age, weighting 147.0 lb, was diagnosed with chronic obstructive pulmonary disease and was treated with Tiotropium (View Usage). Patient had the following side effects: abdominal pain (What is abdominal pain?), urinary retention. Tiotropium dosage: 1 Puff(s) Every Day Inhale.

6054442-1 | Anorexia, Anxiety, Chronic Obstructive Pulmonary Disease, Disturbance In Attention, Emphysema, Malnutrition, Refusal Of Treatment By Patient, Respiratory Failure
on Jan 16, 2009 Female patient from , 47 years of age, was diagnosed with chronic obstructive pulmonary disease, emphysema and was treated with Tiotropium (View Usage). After Tiotropium was administered, patient had the following side effects: anorexia, anxiety (What is anxiety?), chronic obstructive pulmonary disease, disturbance in attention, emphysema, malnutrition, refusal of treatment by patient, respiratory failure. Tiotropium dosage: . During the same period patient was treated with IPRATROPIUMBROMID (View Ipratropiumbromid Review and Ipratropiumbromid Label ), FORMOTEROL FUMARATE (View Formoterol Fumarate Review and Formoterol Fumarate Label ), ACETYLCYSTEINE (View Acetylcysteine Review and Acetylcysteine Label ), PREDNISOLONE (40mg) (View Prednisolone Review and Prednisolone Label ).

5890113-X | Condition Aggravated, Hepatic Failure, Respiratory Failure
Patient was taking Tiotropium (View Usage). Patient experienced the following unwanted or unexpected effects: condition aggravated, hepatic failure, respiratory failure on Sep 15, 2008 from Additional patient health information: Male patient , 34 years of age, was diagnosed with interstitial lung disease, pulmonary fibrosis (What is pulmonary fibrosis?), psoriatic arthropathy and. Tiotropium dosage: . During the same period patient was treated with PREDNISONE (30mg) (View Prednisone Review and Prednisone Label ), DEFLAZACORT (30mg) (View Deflazacort Review and Deflazacort Label ), ALBUTEROL SPIROS (View Albuterol Spiros Review and Albuterol Spiros Label ), AZATHIOPRINE (100mg) (View Azathioprine Review and Azathioprine Label ), METHOTREXATE (View Methotrexate Review and Methotrexate Label ). Patient was hospitalized.

5890083-4 | Condition Aggravated, Hepatic Failure, Respiratory Failure
Adverse event was reported on Sep 15, 2008 by a Male patient taking Tiotropium (View Usage) (Dosage: ) was diagnosed with interstitial lung disease, pulmonary fibrosis (What is pulmonary fibrosis?), psoriatic arthropathy and. Location: , 34 years of age, Patient had the following side effects: condition aggravated, hepatic failure, respiratory failure. During the same period patient was treated with PREDNISONE (30mg) (View Prednisone Review and Prednisone Label ), DEFLAZACORT (30mg) (View Deflazacort Review and Deflazacort Label ), ALBUTEROL SPIROS (View Albuterol Spiros Review and Albuterol Spiros Label ), AZATHIOPRINE (100mg) (View Azathioprine Review and Azathioprine Label ), METHOTREXATE (View Methotrexate Review and Methotrexate Label ). Patient was hospitalized.

5633867-X | Pneumonia
on Feb 21, 2008 Male patient from ITALY , weighting 110.2 lb, was diagnosed with chronic obstructive pulmonary disease and was treated with Tiotropium (View Usage). After Tiotropium was administered, patient had the following side effects: pneumonia (What is pneumonia?). Tiotropium dosage: . Patient was hospitalized.

5382320-X | Angle Closure Glaucoma
on Jul 02, 2007 Female patient from , 62 years of age, was diagnosed with chronic obstructive pulmonary disease and was treated with Tiotropium (View Usage). Patient experienced the following unwanted or unexpected effects: angle closure glaucoma. Tiotropium dosage: . During the same period patient was treated with SYMBICORT FORT (View Symbicort Fort Review and Symbicort Fort Label ), LANSOR (View Lansor Review and Lansor Label ), TENSINOR (View Tensinor Review and Tensinor Label ), INDAPAMIDE (View Indapamide Review and Indapamide Label ). Patient was hospitalized.

5377715-4 | Angle Closure Glaucoma
Patient was taking Tiotropium (View Usage). Patient had the following side effects: angle closure glaucoma on Jul 02, 2007 from Additional patient health information: Female patient , 62 years of age, was diagnosed with chronic obstructive pulmonary disease and. Tiotropium dosage: . During the same period patient was treated with SYMBICORT FORT (View Symbicort Fort Review and Symbicort Fort Label ), LANSOR (View Lansor Review and Lansor Label ), TENSINOR (View Tensinor Review and Tensinor Label ), INDAPAMIDE (View Indapamide Review and Indapamide Label ). Patient was hospitalized.

4874317-0 | Headache
Adverse event was reported on Jan 03, 2006 by a Male patient taking Tiotropium (View Usage) (Dosage: One Inhal Bid) was diagnosed with chronic obstructive pulmonary disease and. Location: UNITED STATES , 61 years of age, weighting 196.7 lb, After Tiotropium was administered, patient had the following side effects: headache (What is headache?).

4730161-6 | Eye Pain
on Jul 28, 2005 Male patient from UNITED STATES , 81 years of age, weighting 188.7 lb, was treated with Tiotropium (View Usage). Patient experienced the following unwanted or unexpected effects: eye pain. Tiotropium dosage: .

4687827-6 | Urinary Hesitation, Urinary Incontinence, Urinary Retention
on Jun 10, 2005 Male patient from , 56 years of age, weighting 178.4 lb, was diagnosed with chronic obstructive pulmonary disease, emphysema and was treated with Tiotropium (View Usage). Patient had the following side effects: urinary hesitation, urinary incontinence (What is urinary incontinence?), urinary retention. Tiotropium dosage: 18mcg Daily Respirator. During the same period patient was treated with ALBUTEROL (View Albuterol Review and Albuterol Label ), DIAZEPAM (View Diazepam Review and Diazepam Label ), FLUNISOLIDE (View Flunisolide Review and Flunisolide Label ), FLUTICASONE PROP (View Fluticasone Prop Review and Fluticasone Prop Label ), FORMOTEROL FUMARATE (View Formoterol Fumarate Review and Formoterol Fumarate Label ), LISINOPRIL (View Lisinopril Review and Lisinopril Label ), MIRTAZAPINE (View Mirtazapine Review and Mirtazapine Label ).

4667317-7 | Bladder Disorder
Patient was taking Tiotropium (View Usage). After Tiotropium was administered, patient had the following side effects: bladder disorder on Mar 19, 2005 from Additional patient health information: Male patient , 70 years of age, was diagnosed with chronic obstructive pulmonary disease and. Tiotropium dosage: 1 Cap Inh Q Day.